Accord BioPharma received FDA approval for 420mg HERCESSI, a biosimilar to Herceptin to treat various kinds of ...

NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...

As part of the acquisition, Organon will acquire psoriasis treatment Vtama, which could soon be approved in atopic dermatitis ...

Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for treating eosinophilic granulomatosis with ...

Lupin has announced a non-exclusive patent licence agreement with Takeda for the commercialisation of Vonoprazan Tablets in ...

Ossium Health is also running the PRESERVE I trial to evaluate the safety and effectiveness of its deep-frozen bone marrow ...

Statistics show incidences of cancer are rising in younger demographics. Tailored therapies offer a solution - if clinical ...

The US FDA has granted approval for MSD’s KEYTRUDA regimen as a first-line treatment for malignant pleural mesothelioma (MPM) ...

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual ...

Optima Pharma has announced it will be exploring key trends and issues in the pharmaceutical industry in its series of expert ...

A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.

The Israeli Ministry of Health granted approval for BeiGene’s TEVIMBRA for unresectable or metastatic oesophageal squamous ...